About this trial
Blood culture (BC) is the gold standard for the definitive diagnosis of bacteraemia, providing the opportunity to recover and identify the causative organism, and optimize subsequent antimicrobial treatment. Detection of bacteraemia is critical for the management of sepsis. This study aims to examine the performance of the blood culture pathway in Gloucestershire Hospitals Trust using data analysis, questionnaires and focus groups. . Information collected will be used to design interventions that could be used to optimise the blood culture pathway
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
paediatric blood culture samples
samples where volume, collection and/or time to incubation data are not recorded on laboratory system and/or blood culture analyser
Trial population
Secondary data: adult blood culture sets received in the microbiology laboratory, between February 2023 and April 2024. Staff member participants: Staff members that collect adult blood cultures within the Trust
Trial design
Other
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Compliance to optimal blood culture (BC) vol (8-10 mls per bottle).
Volume of blood cultures measured in ml.
Compliance to 4- hour time target to incubation of blood culture from collection.
Time taken from collection of blood culture to incubation in the laboratory, recorded in hours and minutes
Time from collection of blood cultures to targeted antibiotics, hours and minutes
Measurement of time (hours, minutes) from time of blood culture collection to time of targeted antibiotic prescribing
Staff experiences related to taking blood cultures
Staff experiences using questionnaires and focus group discussions exploring facilitators and barriers relating to blood culture collection . Staff members will participate by completing the questionnaire and/or attending focus groups.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.